OAT
Ornithine aminotransferase, mitochondrial
Also known as: HOGA, OAT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04181
- Gene
- OAT
- Ensembl
- ENSG00000065154
- Chromosome
- 10
- Canonical length
- 439 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes the mitochondrial enzyme ornithine aminotransferase, which is a key enzyme in the pathway that converts arginine and ornithine into the major excitatory and inhibitory neurotransmitters glutamate and GABA. Mutations that result in a deficiency of this enzyme cause the autosomal recessive eye disease Gyrate Atrophy. Alternatively spliced transcript variants encoding different isoforms have been described. Related pseudogenes have been defined on the X chromosome. [provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
439 residues, UniProt reviewed canonical sequence.
>P04181|OAT
1 MFSKLAHLQR FAVLSRGVHS SVASATSVAT KKTVQGPPTS DDIFEREYKY GAHNYHPLPV
61 ALERGKGIYL WDVEGRKYFD FLSSYSAVNQ GHCHPKIVNA LKSQVDKLTL TSRAFYNNVL
121 GEYEEYITKL FNYHKVLPMN TGVEAGETAC KLARKWGYTV KGIQKYKAKI VFAAGNFWGR
181 TLSAISSSTD PTSYDGFGPF MPGFDIIPYN DLPALERALQ DPNVAAFMVE PIQGEAGVVV
241 PDPGYLMGVR ELCTRHQVLF IADEIQTGLA RTGRWLAVDY ENVRPDIVLL GKALSGGLYP
301 VSAVLCDDDI MLTIKPGEHG STYGGNPLGC RVAIAALEVL EEENLAENAD KLGIILRNEL
361 MKLPSDVVTA VRGKGLLNAI VIKETKDWDA WKVCLRLRDN GLLAKPTHGD IIRFAPPLVI
421 KEDELRESIE IINKTILSFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 736 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 736 nTPM
- duodenum: 706 nTPM
- salivary gland: 212 nTPM
- liver: 152 nTPM
- breast: 140 nTPM
- adrenal gland: 113 nTPM
Single-cell type
- enterocytes: 1,241 nCPM
- breast lactating cells: 381 nCPM
- respiratory deuterosomal cells: 377 nCPM
- parietal cells: 359 nCPM
- paneth cells: 344 nCPM
- erythrocyte progenitors: 282 nCPM
Immune cell
- myeloid DC: 44 nTPM
- neutrophil: 40 nTPM
- classical monocyte: 40 nTPM
- basophil: 38 nTPM
- non-classical monocyte: 37 nTPM
- eosinophil: 36 nTPM
Brain region
- pons: 108 nTPM
- white matter: 96 nTPM
- hypothalamus: 93 nTPM
- cerebral cortex: 90 nTPM
- choroid plexus: 86 nTPM
- cerebellum: 84 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OAT.
Disease | AllUniProt
Conditions OAT is implicated in, by any mechanism.
- Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) MIM:258870
Disease | GeneticClinVar
151 pathogenic / likely-pathogenic of 735 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ornithine aminotransferase deficiency
- Hyperornithinemia
- Retinal dystrophy
- Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia
- Optic atrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- L-proline biosynthetic process
- visual perception
- L-arginine catabolic process to L-glutamate
- L-arginine catabolic process to proline via ornithine
Molecular functions
- identical protein binding
- pyridoxal phosphate binding
- ornithine aminotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aminotransferase class-III
- Pyridoxal phosphate-dependent transferase, major domain
- Pyridoxal phosphate-dependent transferase, small domain
- Pyridoxal phosphate-dependent transferase
- Aminotransferases class-III pyridoxal-phosphate attachment site
- Aminotransferase class-III
- Ornithine aminotransferase
- Class-III Pyridoxal-phosphate-dependent Aminotransferase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OAT as an antibody target. Whether an autoantibody or antibody against OAT could matter depends on whether native OAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...